The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Open accessAbstract
Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In families affected with multiple cases of schizophrenia, the deficit in P50 gating segregates as an autosomal dominant and is linked to the CHRNA7 gene complex, which forms the α7-nicotinic acetylcholine receptor (26).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [26]
Citations
Cites
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citationStrategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
- L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
- W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
- L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
- L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
- M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
- L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
- 10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Roy, M., Mérette, C., & Maziade, M. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600108 · Cited by 5
Hashimoto, K., & Hattori, E. (2007) · Medical psychiatry · doi:10.3109/9781420019544.004 · Cited by 5
Classical Genetic Studies of Schizophrenia
Riley, B., & Kendler, K. (2011) · Wiley eBooks · doi:10.1002/9781444327298.ch12 · Cited by 6
Antipsychotic drugs: recent developments and novel agents
Howard, H. R. (1997) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.7.4.353 · Cited by 5
Genetics, Risk Factors, and Personality Factors
Moises, H. W., & Gottesman, I. I. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_87 · Cited by 5
Genetics of Schizophrenia: Current Findings and Issues
Kennedy, J. L., Pato, M. T., Bauer, A., Carvalho, C. B., & Pato, C. N. (1999) · CNS Spectrums · doi:10.1017/s1092852900011676 · Cited by 5
Animal Models of Schizophrenia
Lipska, B. K., & Weinberger, D. R. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch21 · Cited by 6
Molecular Imaging of 7 Nicotinic Acetylcholine Receptors In Vivo: Current Status and Perspectives
Brust, P., & Deuther‐Conrad, W. (2012) · InTech eBooks · doi:10.5772/23787 · Cited by 4
Mallet, J., Godin, O., Dansou, Y., Mazer, N., Scognamiglio, C., Berna, F. S., Boyer, L., Capdevielle, D., Chéreau, I., d’Amato, T., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722002574 · Cited by 4
Artículo original El uso de endofenotipos en el estudio del componente genético de la esquizofrenia
Miranda, A., López‐Jaramillo, C., Valencia, J. G., & Duque, J. O. (2003) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 4
Anticonvulsants: The Psychotropic and Medically Protective Drugs of the Future
Binder, M. R. (2021) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20210905.18 · Cited by 4
Nicotinic systems in central nervous systems disease: degenerative disorders and beyond
NEWHOUSE, P. A., & Kelton, M. (2000) · Pharmacochemistry library · doi:10.1016/s0165-7208(00)80005-7 · Cited by 4
Preclinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_17 · Cited by 4
General Principles of Psychopharmacology
Williams, J. M., & Grossberg, G. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-74604-3_2 · Cited by 4
Zandona, A. (2020) · Periodicum Biologorum · doi:10.18054/pb.v121-122i3-4.10547 · Cited by 5
Ohno, Y., Taura, D., Okamoto, K., Fujita, H., Honda-Kohmo, K., Matsuo, K., & Sone, M. (2023) · Stem Cells and Development · doi:10.1089/scd.2022.0258 · Cited by 4
Pradhan, A., Mounford, H., Peixinho, J., Rea, E., Epeslidou, E., Scott, J. S., Cull, J., Maxwell, S., Webster, R. G., Beeson, D., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05149-8 · Cited by 4
Özer, S., Ayhan, Y., & Uluşahin, A. (2004) · PubMed · Cited by 4
Hoffman, R. E., & McGlashan, T. H. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63081-2 · Cited by 4
Thinschmidt, J. S., López‐Hernández, G. Y., Ren, K., King, M. A., Meyer, E. M., & Papke, R. L. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.011 · Cited by 4
Apport de la génétique dans les études sur la résilience : l’exemple de l’autisme
Goussé, V. (2005) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2005.09.025 · Cited by 4
Endophenotypes in psychiatric genetics
Chen, A. C. H., Rangaswamy, M., & Porjesz, B. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139025997.030 · Cited by 4
Génétique et psychiatrie : à la recherche de phénotypes.
Bellivier, F., Nosten‐Bertrand, M., & Leboyer, M. (1998) · médecine/sciences · doi:10.4267/10608/983 · Cited by 4
Genetic Markers in Psychiatric Genetics
Bourgeron, T., & Giros, B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-348-8:63 · Cited by 4
Neuronal Nicotinic Receptors and Synaptic Transmission in the Mammalian Central Nervous System
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., Eisenberg, H. M., & Maelicke, A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_13 · Cited by 4
Moises, H. W. (2001) · arXiv (Cornell University) · doi:10.48550/arxiv.cond-mat/0110189 · Cited by 6
Thaker, G. K. (2002) · PubMed · doi:10.1097/01.nmd.0000027590.27232.ed · Cited by 4
Tong, J., Yang, K., Li, W., Wang, L., Yin, Y., Zhou, Y., Huang, J., Zhang, P., Zhao, Y., Chen, S., et al. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae180 · Cited by 3
Shape-shifting conotoxins reveal divergent pore-targeting mechanisms in nicotinic receptors
Bhattacharjee, B., Noviello, C., Rahman, M. M., Mayer, J. P., Gajewiak, J., McIntosh, J. M., Hibbs, R. E., & Stowell, M. H. B. (2025) · Structure · doi:10.1016/j.str.2025.12.003 · Cited by 3
Real-time tilting and twisting motions of ligand-bound states of α7 nicotinic acetylcholine receptor
Yue, Y., Arai, T., Sasaki, D., Kuramochi, M., Inagaki, H., Ohashi, S., Sekiguchi, H., Mio, K., Kubo, T., & Sasaki, Y. C. (2024) · European Biophysics Journal · doi:10.1007/s00249-023-01693-6 · Cited by 3
Nicotinic acetylcholine receptors in the brain
Barrantes, F. J. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00004-4 · Cited by 3
Hersendisfunctie en Event Related Potentials
de Geus, E. J. C. (1997) · Neuropraxis · doi:10.1007/bf03070896 · Cited by 3
Experimental Medicine Approaches in CNS Drug Development
Paul, J. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00005-9 · Cited by 3
Binder, M. R. (2022) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20221001.14 · Cited by 3
Zakaria, W. N. A., Sasongko, T. H., Al-Rahbi, B., Al‐Sowayan, N. S., Ahmad, A. H., Zakaria, R., Ahmi, A., & Othman, Z. (2023) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000336 · Cited by 3
Electrophysiology in Neuropsychiatric Research: A Network Perspective
Winterer, G., Herrmann, W. M., & Coppola, R. (1999) · CNS Spectrums · doi:10.1017/s109285290000119x · Cited by 3
Cholinergic denervation attenuates phencyclidine-induced c-fos responses in rat cortical neurons
Savage, S., Mattsson, A., & Olson, L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.064 · Cited by 3
[Acetylcholine receptor knockout mice].
Mitsui, T. (1999) · PubMed · Cited by 3
Smoller, J. W., Finn, C. T., & Gardner-Schuster, E. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50065-2 · Cited by 3
Callicott, J. H., & Weinberger, D. R. (2000) · Medical radiology · doi:10.1007/978-3-642-58716-0_41 · Cited by 3
Chapter 20 Modeling prefrontal cortex delay cells: the role of dopamine in schizophrenia
Reid, A. G., & Willshaw, D. J. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63083-6 · Cited by 3
Manchia, M., Viggiano, E., Tiwari, A. K., Renou, J., Jain, U., Luca, V. D., & Kennedy, J. L. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902980788 · Cited by 3
Genetik psychiatrischer Störugen
Maier, W., Schwab, S. G., & Rietschel, M. (2003) · Springer eBooks · doi:10.1007/3-540-27386-7_4 · Cited by 3
Discovery of Peptide Drugs from Natural Sources
Henriques, S. T., & Craik, D. J. (2015) · Wiley eBooks · doi:10.1002/9781118995303.ch6 · Cited by 3
Prevention of Schizophrenia: An Impossible Dream?
Rapoport, J. L. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12101287 · Cited by 3
Localization of genes modulating the predisposition to schizophrenia: a revision
Lopes-Machado, E. Z., & Duarte, F. A. M. (2000) · Genetics and Molecular Biology · doi:10.1590/s1415-47572000000300009 · Cited by 3
CURRENT PROGRESS IN SCHIZOPHRENIA RESEARCH
Thaker, G. K. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200206000-00012 · Cited by 3
Convergence of Functional Magnetic Resonance Imaging and Event-Related Potential Methodologies
Erwin, R. J., & Rao, S. M. (2000) · Brain and Cognition · doi:10.1006/brcg.1999.1160 · Cited by 3
More choices for treating voices
Flaum, M. A., & Andreasen, N. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90055-6 · Cited by 3
Schizophrenie und verwandte Störungen — Neurobiologie
Arolt, V., Ohrmann, P., & Rothermundt, M. (2006) · Springer eBooks · doi:10.1007/3-540-30887-3_7 · Cited by 3
Schizophrenia and the environment: speculative interventions
Warner, R. (1999) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00007491 · Cited by 3
Die Katatonien: neue Aspekte zur Ätiologie
Stöber, G. (2003) · psychoneuro · doi:10.1055/s-2003-42185 · Cited by 3
CURRENT PROGRESS IN SCHIZOPHRENIA RESEARCH
Thaker, G. K. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200208000-00009 · Cited by 3
Maelicke, A., Schrattenholz, A. S., & Albuquerque, E. X. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_18 · Cited by 3
Molecular Genetics of Schizophrenia and Comorbid and Related Traits
Ekelund, J. (2001) · Työväentutkimus Vuosikirja · Cited by 3
Novel Approaches for the Treatment of Schizophrenia
Rogers, B. N., & Schmidt, C. J. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41001-0 · Cited by 3
Mastnak-Sokolov, P., Knez, D., Meden, A., Benedik, N. S., Benetik, S. F., Rambaher, M. H., Zorman, M., Nachon, F., Brazzolotto, X., Jardemark, K. E., et al. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111830 · Cited by 3
Genetische Forschung in der Psychiatrie: Fortschritt und Ethische Verantwortung
Deckert, J., & Arolt, V. (2001) · Springer eBooks · doi:10.1007/978-3-642-56818-3_24 · Cited by 2
Neurobiology and Mechanisms of Nicotine Addiction
Gogineni, H. P., Sachs, D. P. L., & Brunzell, D. H. (2023) · Respiratory medicine · doi:10.1007/978-3-031-24914-3_3 · Cited by 2
Exploring Synaptic Pathways in Traumatic Brain Injury: A Cross-Phenotype Genomics Approach
Prapiadou, S., Mayerhofer, E., Georgakis, M. K., Kals, M., Radmanesh, F., Izzy, S., Richardson, S. T., Okonkwo, D. O., Puccio, A. M., Temkin, N. R., et al. (2024) · Journal of Neurotrauma · doi:10.1089/neu.2024.0153 · Cited by 2
Role of Glial Cells and Receptors in Schizophrenia Pathogenesis
Tizabi, Y., Antonelli, M. C., Tizabi, D., & Aschner, M. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04336-8 · Cited by 2
Yang, T., Hao, R.-H., Guo, Y., Papasian, C. J., & Deng, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00004-6 · Cited by 2
McClain, L. L., Segreti, A. M., Nau, S., Shaw, P., Finegold, D. N., Pan, L. A., & Peters, D. G. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12628 · Cited by 2
Developmental disabilities, autism, and schizophrenia at a single locus
Reiter, L. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814409-1.00009-4 · Cited by 2
Proshin, A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.887312 · Cited by 2
Genetische Aspekte der Neuropsychologie psychischer Störungen
Wagner, M. (2004) · Springer eBooks · doi:10.1007/978-3-662-08959-0_8 · Cited by 2
Tobacco Addiction and Psychological Co-morbidities
Ziedonis, D. M., Kalman, D., Kolodziej, M. E., Johnson, C. W., & Kim, S. Y. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0029-6_5 · Cited by 2
Schneider, F., & Deldin, P. J. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47377-1_14 · Cited by 2
Potential therapeutic targets for schizophrenia
Wong, A. H. C., Sanyal, S., Knapp, M., & Tol, H. H. M. V. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.4.571 · Cited by 2
Flórez, J. F. G., & Salazar, D. A. R. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Modeling the Maternal Immune Activation Risk Factor for Schizophrenia
Malkova, N. V., Wu, W., & Hsiao, E. Y. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00011-0 · Cited by 2
Foucher, J., Clauss, J. M. E., Obrecht, A., de Billy, C. D. C., Mainberger, O., Schorr, B., Berna, F. S., & Bonah, C. (2019) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2018.10.022 · Cited by 2
Stern, T., Crutcher, E., McCarthy, J. M., Ali, M. A., Issachar, G., Geva, A. B., Peremen, Z., & Schaaf, C. P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.622329 · Cited by 3
Genetic Studies of Schizophrenia
Riley, B. (2011) · Advances in neurobiology · doi:10.1007/978-1-4419-7197-5_13 · Cited by 4
Pombero, A., & Martinez, S. (2015) · The Journal of comparative neurology · doi:10.1002/cne.23754 · Cited by 2
Environmental interventions in schizophrenia 1: The individual and the domestic levels
Warner, R. (1999) · New Directions for Mental Health Services · doi:10.1002/yd.23319998309 · Cited by 2
Cognitive enhancing drugs for schizophrenia
Raedler, T. J. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.10.001 · Cited by 2
Effects of Smoking on Hormones, Brain, and Behavior
Sidhartha, T., Poland, R. E., & Rao, U. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00108-x · Cited by 2
Genetic Regulation of Nicotine-Related Behaviors and Brain Nicotinic Receptors
Stitzel, J. A., Leonard, S. S., & Collins, A. C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_22 · Cited by 2
Self-citationNeurophysiological Endophenotypes in Early Detection of Schizophrenia
Myles‐Worsley, M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-729-1_10 · Cited by 2
Self-citationGenetic analyses of schizophrenia
Pato, C. N., Schindler, K. M., & Pato, M. T. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0058-7 · Cited by 2
Future contributions on genetics
Krebs, M. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030072 · Cited by 2
Towards a clinical methodology for neuropsychopharmacological research.
Ban, T. A. (2007) · PubMed · Cited by 2
Clinical Methodologies in the Examination of Nicotinic Effects on Cognition
Potter, A., & NEWHOUSE, P. A. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch14 · Cited by 2
Gershon, E. S., & Badner, J. A. (2001) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2001.3.1/esgershon · Cited by 2
Novel antipsychotics and the neuropsychological deficiencies of schizophrenia.
Hawkins, K. A. (2000) · PubMed Central · Cited by 2
Novel Targets for Drug Treatment in Psychiatry
Kurita, M., García‐Bea, A., & González‐Maeso, J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_30 · Cited by 1
Rees, K. A., McCamy, K. M., Danao, C. I., & Winzer‐Serhan, U. H. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156951 · Cited by 1
Winzer‐Serhan, U. H., Ramakrishnan, S., Li, Y., Mada, S., & Reddy, D. S. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115892 · Cited by 1
Woodcock, T. (2010) · UKnowledge (University of Kentucky) · Cited by 1
Progress in the prospective study of the schizophrenia prodrome
Fu, E. J., & Cadenhead, K. S. (2005) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629450 · Cited by 1
Nicotinic modulation of attentional deficits in schizophrenia
Schnur, P., & Hoffman, A. C. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730184.021 · Cited by 1
Neurophysiology of Cognitive Dysfunction in Schizophrenia
Haenschel, C., & Linden, D. E. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_18 · Cited by 1
Mental Disorders Across the Life Span and the Role of Executive Function Networks
Carlson, M. C., Eldreth, D. A., Chuang, Y., & Eaton, W. W. (2012) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195390445.003.0009 · Cited by 2
Developmental Disabilities, Autism, and Schizophrenia at a Single Locus
Urraca, N., & Reiter, L. T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00017-0 · Cited by 1
Horne, M. K., Drago, J., & Nunan, J. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80007-7 · Cited by 1
Cardno, A. G., & Gottesman, I. I. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(200021)97:1
Donnelly, S. L., Wolpert, C. M., Menold, M. M., Bass, M. P., Gilbert, J. R., Cuccaro, M. L., Delong, G. R., & Pericak-Vance, M. A. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000612)96:3
Metadata
- Authors
- Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
- Affiliations
- Baylor College of Medicine (US)
- Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19557
- OpenAlex
- W2144671685
- Cited by
- 1,141
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
- National Institute on Aging (T32AG000029)
- National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
- National Institute on Drug Abuse (R01DA009457)
- National Center for Research Resources (P41RR003655, M01RR000064)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
- MeSH terms
- Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review